Clean Tumor Targets: The Necessary Starting Point for Next-Generation ADCs
Time: 10:15 am
day: Conference Day One
Details:
- Understanding how new ADC linkers and payloads promise incremental improvements in ADC profiles and how transformative improvement requires new targets
- Learning how targeting aberrantly glycosylated glycopeptide epitopes provides exquisitely clean solid tumor selectivity
- Exploring how Glycopeptide targeted ADCs promise to vastly reduce on-target off-tumor toxicity and open access to a broad range of cancer indications